To further investigate whether the genes associated with tumor stemness were altered, we selected a subset of representative genes (SOX2, NANOG, KLF4, CD133, ALDH1, BMI1, ABCG2, CD44, and OCT4) for validation in knockdown and overexpression groups using RT-qPCR analysis. This evidence concerns the gene CD44 and neoplasm.